new concerns about cardiac risk with Meridia
January 2010
See updated information from FDA and Health Canada concerning the withdrawal of Meridia from the U.S. and Canadian markets
You'll hear new concerns about cardiac risk with Meridia.
The manufacturer tried to show that Meridia (sibutramine) could improve cardiovascular outcomes in high-risk patients...by helping them lose weight.
But instead they found a HIGHER risk of heart attacks and strokes in patients taking Meridia.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote